Jiangsu Hualv Biological Technology Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 527.72 million compared to CNY 381.34 million a year ago. Revenue was CNY 527.72 million compared to CNY 381.34 million a year ago.

Net income was CNY 66.92 million compared to net loss of CNY 4.11 million a year ago. Basic earnings per share from continuing operations was CNY 0.5735 compared to basic loss per share from continuing operations of CNY 0.0352 a year ago. Diluted earnings per share from continuing operations was CNY 0.5735 compared to diluted loss per share from continuing operations of CNY 0.0352 a year ago.